Chemical Component Summary

Name5-IODODEOXYURIDINE
Identifiers1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-pyrimidine-2,4-dione
FormulaC9 H11 I N2 O5
Molecular Weight354.099
TypeNON-POLYMER
Isomeric SMILESC1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O
InChIInChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
InChIKeyXQFRJNBWHJMXHO-RRKCRQDMSA-N

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count3
Bond Count29
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00249 
NameIdoxuridine
Groups
  • approved
  • investigational
DescriptionAn analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent.
Synonyms
  • 1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil
  • 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil
  • 1beta-D-2'-Deoxyribofuranosyl-5-iodouracil
  • IdU
  • Idoxuridina
Brand Names
  • Dendrid
  • Herplex
  • Sandoz Idoxuridine
  • Herplex D
IndicationFor use in keratoconjunctivitis and keratitis caused by herpes simplex virus.
Categories
  • Anti-Infective Agents
  • Antiinfectives for Systemic Use
  • Antiviral Agents
  • Antivirals for Systemic Use
  • Deoxyribonucleosides
ATC-Code
  • D06BB01
  • J05AB02
  • S01AD01
CAS number54-42-2

Drug Targets

NameTarget SequencePharmacological ActionActions
DNA-unknownother
Thymidine kinaseMASYPCHQHASAFDQAARSRGHSNRRTALRPRRQQEATEVRLEQKMPTLL...unknownunknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 5905
ChEMBL CHEMBL788
ChEBI CHEBI:147675
CCDC/CSD IDOXUR, IDOXUR01